Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment

IntroductionOvarian cancer is the most lethal gynecological malignancy. Deepening our knowledge of the interactions within the tumor microenvironment (TME) is important for discovering new targeted treatment strategies. Transglutaminase 2 (TG2) is a protein implicated in many biological and pathophy...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Dalia Ibrahim, Melanie Grondin, Kristianne Galpin, Sara Asif, Emily Thompson, Sarah Nersesian, John Abou-Hamad, Maryam Echaibi, Galaxia M. Rodriguez, Pauline Navals, Elizabeth Macdonald, Brianna Ryan, David P. Cook, Jeffrey W. Keillor, Barbara C. Vanderhyden
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Frontiers Media S.A. 2025-07-01
Serie:	Frontiers in Immunology
Ämnen:	ovarian cancer transglutaminase 2 immune modulation targeted therapy metastasis
Länkar:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1639853/full
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!